News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kirn David
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/04/2023 |
4
| Kirn David (CEO) has filed a Form 4 on 4D Molecular Therapeutics, Inc.|
Txns:
| Gifted 600,000 shares
@ $0
Gifted 600,000 shares
@ $0 |
|
| 02/23/2023 |
4
| Kirn David (CEO) has filed a Form 4 on 4D Molecular Therapeutics, Inc.|
Txns:
| Sold 17,090 shares
@ $20.9314, valued at
$357.7k
Sold 907 shares
@ $21.4897, valued at
$19.5k
Sold 16,449 shares
@ $20.224, valued at
$332.7k
|
|
| 02/14/2023 |
4
| Kirn David (CEO) has filed a Form 4 on 4D Molecular Therapeutics, Inc.|
Txns:
| Granted 222,000 options to buy
@ $20.24, valued at
$4.5M
|
|
| 02/08/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/23/2023 |
4
| Kirn David (CEO) has filed a Form 4 on 4D Molecular Therapeutics, Inc.|
Txns:
| Sold 10,899 shares
@ $20.0337, valued at
$218.3k
Sold 8,625 shares
@ $20.1886, valued at
$174.1k
|
|
| 12/19/2022 |
4
| Kirn David (CEO) has filed a Form 4 on 4D Molecular Therapeutics, Inc.|
Txns:
| Sold 31,433 shares
@ $23.5602, valued at
$740.6k
Sold 1,500 shares
@ $24.1327, valued at
$36.2k
Sold 27,595 shares
@ $22.6625, valued at
$625.4k
Sold 26,349 shares
@ $23.3863, valued at
$616.2k
|
|
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2020 |
3
| Kirn David (See Remarks) has filed a Form 3 on 4D Molecular Therapeutics Inc. |
|
|